Skip to content

Drug interactions

Elagolix + Ondansetron

Severity: Minor

Elagolix and Ondansetron: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix is a weak to moderate CYP3A inducer and a P-gp inhibitor, with opposing possible effects on ondansetron exposure. The net effect is uncertain and likely small because ondansetron has several clearance pathways.

What this interaction means in plain words

Elagolix and Ondansetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Elagolix belongs to Musculoskeletal; Ondansetron belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

CYP3A induction may lower ondansetron levels while P-gp inhibition may raise them.

What to do

No dose adjustment is routinely required. Monitor antiemetic response and tolerability.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Ondansetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Ondansetron?

MediHelp rates the interaction as minor. Elagolix and Ondansetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Elagolix is a weak to moderate CYP3A inducer and a P-gp inhibitor, with opposing possible effects on ondansetron exposure. The net effect is uncertain and likely small because ondansetron has several clearance pathways.

How serious is the interaction between Elagolix and Ondansetron?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is routinely required. Monitor antiemetic response and tolerability.

What other medicines interact with Ondansetron?

MediHelp also lists interactions of Ondansetron with, for example, Apomorphine, Thioridazine, Vandetanib. The full list is on the Ondansetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in